Drug Trial Radar · NCT06785454
A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hypertension
Last checked: Nov 19, 2026Latest source record: Aug 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
48
Actual
Start
Feb 28, 2025
Primary completion
Dec 17, 2025
Study completion Dec 29, 2025
Sponsor
- Lead sponsor
- Mineralys Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, care provider)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to assess the effect of lorundrostat taken orally (po) once a day on the Apnea-Hypopnea Index (AHI) in participants with moderate to severe obstructive sleep apnea (OSA) and hypertension.
Conditions
- Obstructive Sleep Apnea
- Hypertension
Interventions
LorundrostatDrug
Lorundrostat tablet.
PlaceboDrug
Lorundrostat matching placebo tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Placebo-adjusted Change From Baseline in AHI at Week 4Time frame: Baseline, Week 4
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
The University of Alabama
Tuscaloosa, Alabama
Chandler Clinical Trials
Chandler, Arizona
Preferred Research Partners Inc.
Little Rock, Arkansas
Orange County Research Institute
Anaheim, California
The Neurology Center of Southern California - Profound Research, LLC
Carlsbad, California
Probe Clinical Research Corporation
Riverside, California
Research Carolina Elite
Denver, Colorado
Nouvelle Clinical Research
Cutler Bay, Florida
Arrow Clinical Trials
Daytona Beach, Florida
PharmaDev Clinical Research Institute, LLC
Miami, Florida
CNS Healthcare - Orlando (Clinical Neuroscience Solutions)
Orlando, Florida
NeuroTrials Research Inc
Atlanta, Georgia
Centricity Research Rincon Pulmonology
Rincon, Georgia
Chicago Research Center Inc
Chicago, Illinois
Centennial Medical Group
Columbia, Maryland
Velocity Clinical Research, Rockville
Rockville, Maryland
Henry Ford Health System/Henry Ford Medical Center - Columbus
Novi, Michigan
Revive Research Institute, Inc
Southfield, Michigan
Healthcare Research Network
Hazelwood, Missouri
Clayton Sleep Institute
St Louis, Missouri
Patient First MD
Middletown, New Jersey
CTI Clinical Research Center
Cincinnati, Ohio
Northwest Research Center
Portland, Oregon
CNS Healthcare - Memphis (Clinical Neuroscience Solutions - Memphis)
Memphis, Tennessee
Huntsville Research Institute LLC
Huntsville, Texas
Sleep Therapy Research Center
San Antonio, Texas
University of Washington
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.